Labcorp Holdings Inc. (LH)
NYSE: LH · Real-Time Price · USD
250.51
+2.66 (1.07%)
Jun 3, 2025, 4:00 PM - Market closed

Labcorp Holdings (LH) Operating Income by Segment

Created with Highcharts 11.4.8Labcorp Holdings Operating Income by Segment (TTM)1.6B1.6B1.6B1.6B1.6B1.6B1.6B1.6B1.6B1.6B1.6B1.6B1.6B1.6B1.7B1.7B1.8B1.8B2.0B2.0B2.4B2.4B2.7B2.7B2.9B2.9B3.2B3.2B3.7B3.7B3.9B3.9B3.5B3.5B2.8B2.8B1.8B1.8B1.1B1.1B466M466M459M459M437M437M425M425M423M423M447M447M546M546M648M648M756M756M801M801M798M798M814M814M822M822M887M887M930M930M913M913M805M805M722M722M656M656M622M622M-269M-269M-268M-268M-269M-269M-273M-273M-382M-382M-389M-389M-407M-407M-397M-397M-292M-292M-278M-278M-277M-277M-309M-309M-281M-281M-267M-267M-235M-235M-199M-199M-196M-196M-191M-191M-176M-176M-159M-159MDiagnosticsDrug DevelopmentGeneral Corporate ExpensesJul '20Jan '21Jul '21Jan '22Jul '22Jan '23Jul '23Jan '24Jul '24Jan '25-2.00B-2.00B4.00B6.00B

History

Date Diagnostics Drug Development General Corporate Expenses
Mar 31, 20251.62B466.00M-268.70M
Dec 31, 20241.61B459.00M-268.30M
Sep 30, 20241.60B437.20M-269.00M
Jun 30, 20241.60B425.30M-273.20M
Mar 31, 20241.57B422.50M-382.10M
Dec 31, 20231.59B446.50M-389.00M
Sep 30, 20231.62B546.00M-406.80M
Jun 30, 20231.68B647.70M-396.80M
Mar 31, 20231.78B756.40M-291.70M
Dec 31, 20222.03B801.10M-277.50M
Sep 30, 20222.41B798.30M-276.80M
Jun 30, 20222.75B813.70M-309.30M
Mar 31, 20222.90B821.50M-280.90M
Dec 31, 20213.21B887.00M-267.00M
Sep 30, 20213.66B929.70M-235.40M
Jun 30, 20213.89B913.30M-199.30M
Mar 31, 20213.54B804.90M-195.70M
Dec 31, 20202.80B721.60M-191.00M
Sep 30, 20201.84B656.40M-176.00M
Jun 30, 20201.14B621.70M-159.00M
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.